Stäubli Robotics Unveils Groundbreaking Sterimove at INTERPHEX 2026

Stäubli Robotics, renowned for its leadership in industrial automation, is set to present an innovative stride in pharmaceutical automation at INTERPHEX 2026. During the event, taking place from April 21-23, 2026, at the Javits Center in New York City, Stäubli will introduce the enhanced Sterimove, touted as the world's first mobile pharma robot designed for aseptic environments. This advancement epitomizes the company's commitment to improving safety, efficiency, and compliance in pharmaceutical manufacturing.

A New Era in Pharmaceutical Robotics

The latest version of the Sterimove is engineered to meet the rigorous demands of Grade A, B, C, and D cleanroom environments. With a focus on contamination control, the Sterimove is constructed from cleanroom-compatible materials and features a fully sealed architecture. This meticulous design ensures that it not only adheres to but exceeds the standard hygienic design guidelines and established decontamination workflows.

Incorporating advanced mobility features, the Sterimove includes cutting-edge collision avoidance sensing systems, dual emergency stop mechanisms, and clear status lighting to enhance safety during operations. The benefits don’t stop there; the robot is optimized for operational efficiency, promising streamlined material flow and rapid batch changeovers while providing seamless integration with upstream and downstream equipment.

Discover the Sterimove at INTERPHEX

Attendees at INTERPHEX 2026 can visit Stäubli at booth 3443 to experience the capabilities of the Sterimove firsthand. Demonstrations will showcase how this mobile robot operates within cleanroom environments, placing particular emphasis on its role in enhancing automation strategies for pharmaceutical companies.

Moreover, visitors will be introduced to the Stäubli × AST aseptic workflow, featuring the VSM-C cart-based Vial Sealing Module. This integration reflects Stäubli's extensive portfolio—from Stericlean+ isolator-grade robots to accessPharma solutions—all supporting various stages of the pharmaceutical manufacturing lifecycle.

Empowering the Future of Pharmaceuticals

Olivier Cremoux, Head of Robotics for Stäubli in North America, articulated the motivation behind introducing the Sterimove: "Our objective is to provide pharmaceutical manufacturers with added reassurance by merging unparalleled hygienic design with the proven efficiencies of mobile robotics. The solutions we showcase at INTERPHEX reaffirm our dedication to fostering a pharmaceutical production environment that is not only safer but also more resilient and reliable."

With decades of experience across sectors such as biotechnology, medical device manufacturing, and high-precision industrial applications, Stäubli Robotics continues to lead the charge in developing advanced automation solutions that prioritize performance and safety.

Conclusion

Stäubli Robotics is poised to make a significant impact at INTERPHEX 2026 with the unveiling of the Sterimove, setting new standards for mobile pharmaceutical automation. As the company demonstrates its commitment to excellence and innovation, attendees are encouraged to engage with the North American Life Sciences team at the event to discuss tailored sterile-automation strategies and the future advancements in the industry.